Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

SLE (Systemic Lupus) · Systemic Sclerosis · ANCA Associated Vasculitis · Idiopathic Inflammatory Myopathies · Sjogren's Syndrome · Autoimmune Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Third the People's Hospital of Bengbu, Bengbu, Anhui, China
Contact: Study coordinator (Wei Han Wang, Doctor) · whw2139@sina.com · 13955281350

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis · Sjogren's Syndrome (SS)

Abroad (travel likely)RecruitingPHASE1

Xuzhou, China · Xuzhou, China

A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Sjogren's Syndrome (SS) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Idiopathic Inflammatory Myopathy (IIM) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Beijing, China · Beijing, China

Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

SLE (Systemic Lupus) · Sjogren's Syndrome · Systemic Scleroderma

Abroad (travel likely)RecruitingPHASE1

Taiyuan, China